Trial Outcomes & Findings for The Secure Messaging for Medication Reconciliation Tool (SMMRT) Trial (NCT NCT02482025)

NCT ID: NCT02482025

Last Updated: 2020-11-19

Results Overview

Medication discrepancies (discrepancies between what the patient is taking and what is in the medical record) identified 30 days after hospitalization via telephone interview and review of medical record

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

240 participants

Primary outcome timeframe

30 days after hospitalization

Results posted on

2020-11-19

Participant Flow

Participant milestones

Participant milestones
Measure
Usual Care
Usual care delivered at VA Boston
SMMRT
Receives Usual Care PLUS SMMRT Intervention SMMRT: Includes My HealtheVet registration and enrollment
Overall Study
STARTED
122
118
Overall Study
COMPLETED
122
118
Overall Study
NOT COMPLETED
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

The Secure Messaging for Medication Reconciliation Tool (SMMRT) Trial

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Usual Care
n=122 Participants
Usual care delivered at VA Boston
SMMRT
n=118 Participants
Receives Usual Care PLUS SMMRT Intervention SMMRT: Includes My HealtheVet registration and enrollment
Total
n=240 Participants
Total of all reporting groups
Age, Continuous
66.1 years
STANDARD_DEVIATION 11.8 • n=5 Participants
63.4 years
STANDARD_DEVIATION 11.7 • n=7 Participants
64.9 years
STANDARD_DEVIATION 11.7 • n=5 Participants
Sex: Female, Male
Female
10 Participants
n=5 Participants
8 Participants
n=7 Participants
18 Participants
n=5 Participants
Sex: Female, Male
Male
112 Participants
n=5 Participants
110 Participants
n=7 Participants
222 Participants
n=5 Participants
Race/Ethnicity, Customized
Race · White
104 Participants
n=5 Participants
100 Participants
n=7 Participants
204 Participants
n=5 Participants
Race/Ethnicity, Customized
Race · Non-White
18 Participants
n=5 Participants
18 Participants
n=7 Participants
36 Participants
n=5 Participants
MyHealtheVet: Yes, No
My HealtheVet - Yes
107 Participants
n=5 Participants
105 Participants
n=7 Participants
212 Participants
n=5 Participants
MyHealtheVet: Yes, No
My HealtheVet - No
15 Participants
n=5 Participants
13 Participants
n=7 Participants
28 Participants
n=5 Participants

PRIMARY outcome

Timeframe: 30 days after hospitalization

Population: Intention to treat.

Medication discrepancies (discrepancies between what the patient is taking and what is in the medical record) identified 30 days after hospitalization via telephone interview and review of medical record

Outcome measures

Outcome measures
Measure
Usual Care
n=122 Participants
Usual care delivered at VA Boston
SMMRT
n=118 Participants
Receives Usual Care PLUS SMMRT Intervention SMMRT: Includes My HealtheVet registration and enrollment
Medication Discrepancies
6.4 Medication Discrepancies
Standard Deviation 4.6
4.4 Medication Discrepancies
Standard Deviation 3.2

SECONDARY outcome

Timeframe: 30 days

Population: Intention to Treat.

Hospital utilization, defined as re-admissions or emergency department utilization, within 30 days of hospital discharge.

Outcome measures

Outcome measures
Measure
Usual Care
n=122 Participants
Usual care delivered at VA Boston
SMMRT
n=118 Participants
Receives Usual Care PLUS SMMRT Intervention SMMRT: Includes My HealtheVet registration and enrollment
Hospital Utilization
41 Participants
35 Participants

Adverse Events

Usual Care

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

SMMRT

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Steven R. Simon, MD

VA Greater Los Angeles Healthcare System

Phone: 310.268.3132

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place